1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow László Mangel: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma Selegiline, Docetaxel - Metastatic Castration-resistant Prostate Cancer, Adenocarcinoma of the Prostate | Phase 2 | Unknown | László Mangel | 110 | 2020-05-18 | 2020-10-14 |
Docetaxel (1) · Selegiline (1)
Hungary (1)
2019 (1)